Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sleep

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Eye (London, England)|September 11, 2004
A randomised, double-blind trial of topical ketorolac vs artificial tears for the treatment of episcleritisC P R Williams, A C Browning, T J Sleep, et al.
Eye (London, England)|February 22, 2014
The development of a virtual reality training programme for ophthalmology: study must take into account visual acuity and stereopsisA J Swampillai, S Waqar, J C Park, et al.
European Urology|April 2, 2003
Effects of visual sexual stimuli and apomorphine SL on cerebral activity in men with erectile dysfunctionJörn H Hagemann, Georg Berding, Sven Bergh, et al.
The American Journal of Cardiology|January 21, 2011
Efficacy of fenofibric acid plus statins on multiple lipid parameters and its safety in women with mixed dyslipidemiaAnne C Goldberg, Vera Bittner, Carl J Pepine, et al.
American Heart Journal|October 12, 2010
Efficacy and safety of fenofibric acid in combination with atorvastatin and ezetimibe in patients with mixed dyslipidemiaPeter H Jones, Anne C Goldberg, Howard R Knapp, et al.
American Heart Journal|December 17, 2008
Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia: a phase 3, randomized, controlled studySyed M Mohiuddin, Carl J Pepine, Maureen T Kelly, et al.
Cancer|September 12, 2008
Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancerJoel B Nelson, William Love, Joseph L Chin, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 9, 2010
Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trialsPeter H Jones, Kenneth Cusi, Michael H Davidson, et al.
Diabetes Care|June 25, 2010
The effects of fenofibric acid alone and with statins on the prevalence of metabolic syndrome and its diagnostic components in patients with mixed dyslipidemiaHarold E Bays, Eli M Roth, James M McKenney, et al.
Clinical Drug Investigation|December 10, 2009
Year two assessment of fenofibric acid and moderate-dose statin combination: a phase 3, open-label, extension studyMark S Kipnes, Eli M Roth, James M Rhyne, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Eye (London, England)|September 11, 2004
A randomised, double-blind trial of topical ketorolac vs artificial tears for the treatment of episcleritisC P R Williams, A C Browning, T J Sleep, et al.
Eye (London, England)|February 22, 2014
The development of a virtual reality training programme for ophthalmology: study must take into account visual acuity and stereopsisA J Swampillai, S Waqar, J C Park, et al.
European Urology|April 2, 2003
Effects of visual sexual stimuli and apomorphine SL on cerebral activity in men with erectile dysfunctionJörn H Hagemann, Georg Berding, Sven Bergh, et al.
The American Journal of Cardiology|January 21, 2011
Efficacy of fenofibric acid plus statins on multiple lipid parameters and its safety in women with mixed dyslipidemiaAnne C Goldberg, Vera Bittner, Carl J Pepine, et al.
American Heart Journal|October 12, 2010
Efficacy and safety of fenofibric acid in combination with atorvastatin and ezetimibe in patients with mixed dyslipidemiaPeter H Jones, Anne C Goldberg, Howard R Knapp, et al.
American Heart Journal|December 17, 2008
Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia: a phase 3, randomized, controlled studySyed M Mohiuddin, Carl J Pepine, Maureen T Kelly, et al.
Cancer|September 12, 2008
Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancerJoel B Nelson, William Love, Joseph L Chin, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 9, 2010
Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trialsPeter H Jones, Kenneth Cusi, Michael H Davidson, et al.
Diabetes Care|June 25, 2010
The effects of fenofibric acid alone and with statins on the prevalence of metabolic syndrome and its diagnostic components in patients with mixed dyslipidemiaHarold E Bays, Eli M Roth, James M McKenney, et al.
Clinical Drug Investigation|December 10, 2009
Year two assessment of fenofibric acid and moderate-dose statin combination: a phase 3, open-label, extension studyMark S Kipnes, Eli M Roth, James M Rhyne, et al.
Pageof 8